type here...
type here...
START FREE TRIAL

M&A

Technology & AIHealthcareM&AConsumer & RetailMiscellaneousEnergy

Everyone Thinks Eli Lilly Is A Weight-Loss Stock. That’s The Trap

M&A Ishan Majumdar -
Eli Lilly (NYSE:LLY) is having one of those rare market moments where everyone thinks they understand the story. Weight-loss drugs are booming, Novo Nordisk...

Amazon vs Starlink Is The Story; But The REAL SHIFT Is Elsewhere!

M&A Ishan Majumdar -
Amazon (NASDAQ:AMZN) has never been shy about spending big when it sees a control point forming.The $10.8 billion Globalstar deal may be the clearest...
spot_imgspot_img

The “Boring” Healthcare Stock Making A $5 Billion POWER MOVE!

M&A Ishan M. -
The market loves excitement. But money is often made in boredom. That is what makes Gilead Sciences (NASDAQ:GILD) such...

This “Broken” Biotech Just Forced Wall Street To Blink

M&A Ishan Majumdar -
Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle on Tuesday. What changed was the price investors were willing...

This Widely Held “Defensive” Stock Is Now Tied To A Large Scale Merger

M&A Ishan Majumdar -
For years, McCormick (NYSE:MKC) has been framed as one of those dependable staples names investors can tuck away and...

Did Mastercard Just Buy Growth, Or A REAL New Rail With Hidden Execution Risk?

M&A Ishan Majumdar -
BVNK’s platform lets businesses send, receive, store, and convert digital currencies through one system. That sounds simple, but the...

Did Apple’s MotionVFX Acquisition Just DEEPEN Its Creator Ecosystem Moat?

M&A Ishan Majumdar -
Apple (NASDAQ:AAPL) has been busy giving investors plenty to chew on. The company just posted a record quarter, with...

Is Meta’s Moltbook Deal About Social Media … Or The Future Of AI Agents?

M&A Ishan Majumdar -
Recent developments around Meta Platforms (NASDAQ:META) suggest the company is continuing its aggressive push into artificial intelligence infrastructure and...
Load more

Everyone Thinks Eli Lilly Is A Weight-Loss Stock. That’s The Trap

M&A Ishan Majumdar -
Eli Lilly (NYSE:LLY) is having one of those rare market moments where everyone thinks they understand the story. Weight-loss...

Amazon vs Starlink Is The Story; But The REAL SHIFT Is Elsewhere!

M&A Ishan Majumdar -
Amazon (NASDAQ:AMZN) has never been shy about spending big when it sees a control point forming.The $10.8 billion Globalstar...

The “Boring” Healthcare Stock Making A $5 Billion POWER MOVE!

M&A Ishan M. -
The market loves excitement. But money is often made in boredom. That is what makes Gilead Sciences (NASDAQ:GILD) such...

This “Broken” Biotech Just Forced Wall Street To Blink

M&A Ishan Majumdar -
Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle on Tuesday. What changed was the price investors were willing...

This Widely Held “Defensive” Stock Is Now Tied To A Large Scale Merger

M&A Ishan Majumdar -
For years, McCormick (NYSE:MKC) has been framed as one of those dependable staples names investors can tuck away and...

Did Mastercard Just Buy Growth, Or A REAL New Rail With Hidden Execution Risk?

M&A Ishan Majumdar -
BVNK’s platform lets businesses send, receive, store, and convert digital currencies through one system. That sounds simple, but the...

Did Apple’s MotionVFX Acquisition Just DEEPEN Its Creator Ecosystem Moat?

M&A Ishan Majumdar -
Apple (NASDAQ:AAPL) has been busy giving investors plenty to chew on. The company just posted a record quarter, with...

Is Meta’s Moltbook Deal About Social Media … Or The Future Of AI Agents?

M&A Ishan Majumdar -
Recent developments around Meta Platforms (NASDAQ:META) suggest the company is continuing its aggressive push into artificial intelligence infrastructure and...

Agilent’s $950M Biocare Acquisition Could Unlock A Powerful Recurring Revenue Flywheel

M&A Ishan Majumdar -
The diagnostics and life sciences equipment industry rarely stands still. But recent developments around Agilent Technologies (NYSE:A) have drawn...

Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!

M&A Ishan M. -
It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong fiscal third quarter, the company is...

Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?

M&A Ishan Majumdar -
Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline add-on in a year already defined...

Is Apple Outflanking Meta With This Q.AI Move?

M&A Ishan Majumdar -
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Everyone Thinks Eli Lilly Is A Weight-Loss Stock. That’s The Trap

0
Eli Lilly (NYSE:LLY) is having one of those rare...

Amazon Earnings Pre-Mortem: THIS Is What’s Making Investors Nervous!!

0
Amazon reports earnings this week, and the setup looks...

Alphabet Earnings Pre-Mortem: The AI Bill Comes Due

0
Alphabet reports this week, and the setup is unusually...

Microsoft Earnings: Why Azure Growth Could Reprice The Entire Stock

0
Microsoft doesn’t need to beat earnings this quarter. It...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.